![Ulrich Dauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Dauer
Director/Board Member at
Atriva Therapeutics GmbH
Profile
Ulrich Dauer was the founder of 4SC AG, where he held the title of Chief Executive Officer from 1997 to 2013.
He is currently a Non-Executive Director at Atriva Therapeutics GmbH.
Dr. Dauer's former positions include Chief Executive Officer at OMEICOS Therapeutics GmbH and Ventaleon GmbH, and Chief Strategy Officer at Vectura GmbH.
He was also the Chief Executive & Financial Officer at Vivoryon Therapeutics NV from 2018 to 2021.
Dr. Dauer obtained a doctorate degree from Julius-Maximilians-Universität Würzburg.
Ulrich Dauer active positions
| Companies | Position | Start |
|---|---|---|
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Director/Board Member | - |
Former positions of Ulrich Dauer
| Companies | Position | End |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Chief Executive Officer | 13/08/2023 |
| 4SC AG | Chief Executive Officer | 30/03/2013 |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Chief Executive Officer | - |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Chief Executive Officer | - |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Corporate Officer/Principal | - |
Training of Ulrich Dauer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
- Stock Market
- Insiders
- Ulrich Dauer
